Holen Sie sich die Stockscreener-App
21.48
1.65%
-0.36
Handel nachbörslich:
21.51
0.03
+0.14%
Immunome Inc Aktie (IMNM) Neueste Nachrichten
Immunome CSO Sells Shares: Transaction Details & Company SnapshotNews and Statistics - IndexBox
Immunome (IMNM) Is Up 11.4% After CEO Share Buy And Positive Phase III DataWhat's Changed - Sahm
Immunome's Chief Scientist Trimmed His Stake. A Planned FDA Submission Tells You More - AOL.com
Insider Sell: What is the long term forecast for Immunome Inc stockDividend Hike & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
Immunome's Chief Scientist Trimmed His Stake. A Planned FDA Submission Tells You More - The Motley Fool
A Look At Immunome (IMNM) Valuation After Oncology Progress EPS Upgrades And CEO Insider Buying - Sahm
Immunome, Inc. (IMNM) stock price, news, quote and history - Yahoo Finance Singapore
Immunome Inc (IMNM) CSO Higgins sells $204,238 in stock By Investing.com - Investing.com Canada
Immunome CFO Rosett sells $1.4m in shares By Investing.com - Investing.com Canada
Immunome Inc (IMNM) CSO Higgins sells $204,238 in stock - Investing.com
Immunome CFO Rosett sells $1.4m in shares - Investing.com
Insider Selling: Immunome (NASDAQ:IMNM) Insider Sells 9,438 Shares of Stock - MarketBeat
Insider Selling: Immunome (NASDAQ:IMNM) CFO Sells $1,424,800.00 in Stock - MarketBeat
Immunome (IMNM) CSO pre-planned 9,438-share sale under Rule 10b5-1 - Stock Titan
Immunome (IMNM) CFO exercises 71,561 options and sells 65,000 shares - Stock Titan
IMNM (NASDAQ: IMNM) Form 144/A: 65,000 shares proposed sale via Fidelity - Stock Titan
Tema Etfs LLC Has $2.19 Million Position in Immunome, Inc. $IMNM - MarketBeat
SG Americas Securities LLC Raises Stock Position in Immunome, Inc. $IMNM - MarketBeat
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PharmiWeb.com
Immunome reports inducement grants under Nasdaq listing rule 5635(c)(4) - marketscreener.com
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Proposed common-share sale reported by IMNM (NASDAQ: IMNM) - Stock Titan
IMNM (NASDAQ: IMNM) files Form 144 for proposed stock sales - Stock Titan
Immunome (IMNM) Moves 13.3% Higher: Will This Strength Last? - qz.com
Immunome (NASDAQ: IMNM) CSO gifts 6,291 shares, retains 31,438 - Stock Titan
Immunome (IMNM) Surges by 13.3%: Can This Momentum Continue? - Bitget
Tuesday’s insider activity: CEO doubles down on biotech stock By Investing.com - za.investing.com
Volume Summary: Can Immunome Inc be the next market leader2026 Trade Ideas & Growth Focused Stock Pick Reports - baoquankhu1.vn
Goldman Sachs Initiates Coverage of Immunome (IMNM) with Buy Recommendation - MSN
Immunome (NASDAQ:IMNM) Stock Price Up 9.4%What's Next? - MarketBeat
Insider Buying: Clay Siegall Acquires Shares of Immunome Inc (IM - gurufocus.com
Immunome Insider Bought Shares Worth $500,602, According to a Recent SEC Filing - marketscreener.com
Immunome CEO Clay Siegall buys $500k in shares By Investing.com - Investing.com South Africa
Immunome CEO Clay Siegall buys $500k in shares - investing.com
Immunome (IMNM) CEO adds 25,450 shares in $19.67 stock purchase - Stock Titan
Immunome Inc Stock: Clinical-Stage Biotech Targeting Cancer and Infectious Diseases with Innovative - AD HOC NEWS
Recap Report: What is the long term forecast for Immunome Inc stockWeekly Investment Summary & Long-Term Safe Investment Ideas - baoquankhu1.vn
Vanguard disaggregates holdings; IMNM shows 0 shares after realignment (IMNM) - Stock Titan
Don't Ignore The Insider Selling In Immunome - simplywall.st
Immunome Insider Sold Shares Worth $1,335,626, According to a Recent SEC Filing - marketscreener.com
Immunome Inc: director Wagenheim sells $1.3m in shares By Investing.com - Investing.com UK
Director Philip Wagenheim Sells 65,000 Shares of Immunome Inc (I - gurufocus.com
Immunome (NASDAQ:IMNM) Director Philip Wagenheim Sells 28,200 Shares - MarketBeat
Philip Wagenheim Sells 36,800 Shares of Immunome (NASDAQ:IMNM) Stock - marketbeat.com
Immunome Inc: director Wagenheim sells $1.3m in shares - Investing.com
Immunome (IMNM) director sells 65,000 shares in open market - Stock Titan
IMNM PE Ratio & Valuation, Is IMNM Overvalued - intellectia.ai
Immunome Inc stock surges on breakthrough oncology data, drawing DACH biotech investor interest - AD HOC NEWS
Immunome, Inc. (NASDAQ:IMNM) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Form 144 Immunome Inc. For: 20 March By Investing.com - Investing.com Australia
Smart Money: Is Immunome Inc forming a breakout patternQuarterly Portfolio Review & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Form 144 Immunome Inc. For: 20 March - Investing.com
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):